New York State Common Retirement Fund’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.62M	Buy	200,472 +5,063	+3%	+$222K	0.01%	730
2025 Q4	$7.55M	Buy	195,409 +2,178	+1%	+$83.1K	0.01%	862
2025 Q3	$6.82M	Sell	193,231 -3,062	-2%	-$111K	0.01%	935
2025 Q2	$7.07M	Buy	196,293 +7,000	+4%	+$232K	0.01%	912
2025 Q1	$5.89M	Sell	189,293 -77,522	-29%	-$2.46M	0.01%	976
2024 Q4	$6.81M	Sell	266,815 -13,500	-5%	-$358K	0.01%	965
2024 Q3	$7.93M	Sell	280,315 -47,251	-14%	-$1.31M	0.01%	890
2024 Q2	$8.64M	Buy	327,566 +16,251	+5%	+$450K	0.01%	880
2024 Q1	$9.45M	Sell	311,315 -78,967	-20%	-$2.33M	0.01%	838
2023 Q4	$11M	Sell	390,282 -37,697	-9%	-$1.04M	0.02%	780
2023 Q3	$11.6M	Sell	427,979 -58,028	-12%	-$1.72M	0.02%	748
2023 Q2	$14.9M	Sell	486,007 -16,880	-3%	-$572K	0.02%	700
2023 Q1	$18.1M	Buy	502,887 +4,845	+1%	+$180K	0.02%	609
2022 Q4	$19.7M	Buy	498,042 +3,807	+0.8%	+$159K	0.03%	569
2022 Q3	$19.9M	Sell	494,235 -23,616	-5%	-$1.01M	0.03%	529
2022 Q2	$21.8M	Buy	517,851 +123,850	+31%	+$5.08M	0.03%	507
2022 Q1	$15.3M	Buy	394,001 +6,891	+2%	+$271K	0.02%	769
2021 Q4	$15.4M	Sell	387,110 -5,571	-1%	-$216K	0.02%	795
2021 Q3	$14.2M	Buy	392,681 +19,804	+5%	+$770K	0.02%	841
2021 Q2	$15.3M	Buy	372,877 +1,377	+0.4%	+$58.6K	0.02%	793
2021 Q1	$16.2M	Buy	371,500 +235,000	+172%	+$11.1M	0.02%	734
2020 Q4	$6.83M	Buy	+136,500	New	+$5.79M	0.01%	1132